Key facts
- It has raised $780K; the latest was Accelerator/Incubator ($70K) in Mar 2026.
- Notable investors include Keihanna Global Acceleration Program, CoInvest Capital, BSV Ventures, EIT Health, EPIC-X — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for BrachyDOSE
- ·The full record, as it builds
Funding rounds
No funding rounds for BrachyDOSE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrachyDOSE
Developer of a medical technology designed to monitor radiation injuries during cancer treatments. The company's product utilizes a smart sensor placed near the tumor site to collect data on injury type and probability, enabling healthcare professionals to minimize side effects, optimize treatment efficacy, and enhance patient recovery by reducing hospital stays and overall costs.
- Sector
- Healthcare
- HQ
- Kaunas, Lithuania
- Founded
- 2014
- Employees
- 3
- Website
- brachydose.net/
- Ownership
- Privately Held (backing)
BrachyDOSE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrachyDOSE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrachyDOSE in its N-PORT filings yet. We sweep new filings monthly.